Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.50 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.266NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.253NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.305NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AA.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.241NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.33NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.326NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.255NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.303NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AA.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.173NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.362.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.48NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.520NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.38NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.521NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.383NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.117NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.157NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.187NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.30NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.213NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.12NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.341NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.89NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.23NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.30NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.315NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.204NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.50NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.170NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.232NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.84NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.76NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.301NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.269NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.234NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Z.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
V.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.22NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.282NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.131NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.274NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.25NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.235NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.65NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.45NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used